THE XTRAC®
ADVANTAGE
XTRAC is a 308nm excimer laser that delivers a precisely targeted therapeutic beam of UVB light for the treatment of psoriasis, vitiligo, and atopic dermatitis. It can be used on all skin types, adults and children, and any area of your body without harming the healthy surrounding skin.
EFFECTIVE TREATMENT
Symptoms reduced generally in as little as 4 weeks.
LONG-LASTING RELIEF
Patients typically experience several months free of symptoms.
PAIN
FREE
Virtually no side effects. Does not suppress the immune system systemically.
NO
DRUGS
No need for messy creams or a daily skin regimen.
COVERED BY INSURANCE
Covered by all major insurance for psoriasis, including Medicare and Medicaid. Available by prescription.
Other Psoriasis Treatment Options VS. XTRAC Advantages
TOPICAL TREATMENTS
VS
XTRAC TREATMENT
- No messy creams and daily skincare regimen
- No reduction in effectiveness
- Effective on hard to treat areas (scalp, elbows, etc.)
- No risk of skin thinning or stretch marks
BIOLOGICS
VS
XTRAC TREATMENT
- No worry of harmful side effects such as:
- Liver damage
- Birth defects
- Heart failure
- No monthly injections
- Much lower costs
STANDARD PHOTOTHERAPY
VS
XTRAC TREATMENT
- No UV exposure to healthy skin
- Significantly fewer treatments
*Side Effects/Risks:
XTRAC has none of the drawbacks often associated with other psoriasis treatments such as premature aging of healthy skin, skin thinning, resistance to medication, or potential negative systemic side effects. Some patients, however, experience a reaction similar to sunburn or blistering at the site of the treated area and in some cases, an increase in pigmentation may occur.
**Results may vary, talk to your doctor about the right treatment protocol for you.
BACKED BY SCIENCE
Backed By Science & Scientifically Proven.
Click Arrows to Learn More
THE EXCIMER LASER
The XTRAC Excimer Laser has been recognized by dermatologists worldwide as the market leader in the treatment of psoriasis, vitiligo, and atopic dermatitis. Using a sophisticated liquid light guide system to deliver a targeted, super-narrowband UVB to affected areas, the concentrated light allows for the delivery of high doses of UVB for rapid therapeutic clearing without the worry of harmful side effects of invasive, systemic agents.
THE DEVELOPMENT OF XTRAC
For decades, dermatologists have used ultra violet light therapy for the effective and safe treatment of many skin disorders, including psoriasis. Medical engineers and research teams in coordination with Harvard Medical School and the Wellman Center of PhotoMedicine in Boston created the XTRAC to produce a monochromatic wavelength (308nm) of ultraviolet light known to positively impact the psoriasis action spectrum.
SCIENTIFIC PROOF
XTRAC was FDA cleared in 2000 and cited in over 150 clinical studies and research programs with findings published in peer-reviewed medical journals around the world. XTRAC is endorsed by the National Psoriasis Foundation and the technology is part of the approved clinical protocols recommended by the American Academy of Dermatology.
THE EXCIMER LASER
The XTRAC Excimer Laser has been recognized by dermatologists worldwide as the market leader in the treatment of psoriasis, vitiligo, and atopic dermatitis. Using a sophisticated liquid light guide system to deliver a targeted, super-narrowband UVB to affected areas, the concentrated light allows for the delivery of high doses of UVB for rapid therapeutic clearing without the worry of harmful side effects of invasive, systemic agents.
THE DEVELOPMENT OF XTRAC
For decades, dermatologists have used ultra violet light therapy for the effective and safe treatment of many skin disorders, including psoriasis. Medical engineers and research teams in coordination with Harvard Medical School and the Wellman Center of PhotoMedicine in Boston created the XTRAC to produce a monochromatic wavelength (308nm) of ultraviolet light known to positively impact the psoriasis action spectrum.
SCIENTIFIC PROOF
XTRAC was FDA cleared in 2000 and cited in over 150 clinical studies and research programs with findings published in peer-reviewed medical journals around the world. XTRAC is endorsed by the National Psoriasis Foundation and the technology is part of the approved clinical protocols recommended by the American Academy of Dermatology.
XTRAC SAMPLE STUDIES
XTRAC sample studies from 150+ clinical studies.
Multicenter Psoriasis Study1
VITILIGO Study2
Out of 221 vitiligo patches treated, 50.6% showed 75% pigmentation or more, 25.5% achieved 100% pigmentation of their patches, and 64.3% showed 50% pigmentation or more. Lesions on the face responded better than lesions elsewhere.
CONCLUSION: The 308-nm xenon chloride excimer laser is an effective and safe modality for the treatment of vitiligo, with good results achieved in a relatively short duration of time
SCALP Study3
All patients improved. 17/35 (49%) of patients cleared>95% (mean: 21 treatments; range: 6-52) and 16/35 (45%) cleared 50-95%.
CONCLUSION: The excimer laser is a successful approach to treatment of psoriasis of the scalp being a simple treatment that can be performed in a short period of time and which has a high rate of effective
PEDIATRIC Study4
1. Multicenter Psoriasis Study – Feldman SR, Mellen BG, Housman TS, Fitzpatrick RE, Geronemus RG, Friedman PM, Vasily DB, Morison WL. Efficacy of the 308-nm excimer laser for treatment of psoriasis: Results of a multicenter study. J Am Acad of Dermatol; vol. 46, no. 6, June 2002, pp. 900-906
2. Vitiligo Study – Suhail Hadi, Patricia Tinio, Khalid Al-Ghaithi, Haitham Al-Qari, Mohammad Al-Helalat, Mark Lebwohl, and James Spencer. Photomedicine and Laser Surgery. Treatment of Vitiligo Using the 308-nm Excimer Laser. Jun 2006.ahead of printhttps://doi.org/10.1089/pho.2006.24.354
3. Scalp Study – Morison WL, Atkinson DF and Werthman L. Effective treatment of scalp psoriasis using the excimer (308nm) laser. Photodermatol Photoimmunol Photomed 2006; 22: 181-183
4. Pediatric Study – Pahlajani N, Katz BJ, Lonzano AM, Murphy F and Gottlieb A. Comparison of the Efficacy and Safety of the 308nm Excimer laser for the Treatment of Localized Psoriasis in Adults and in Children: A Pilot Study. Pediatric Dermatology Vol. 22 No. 2, March/April 2005, pp. 161-165
Induration Protocol Study – Taneja A, Trehan M, Taylor C. 308-nm Excimer Laser for the Treatment of Psoriasis – Induration-Based Dosimetry. Arch Dermatol, Vol. 139, June 2003, pp. 759-764
High Dose Protocol Study – Michael Abrouk,1 Ethan Levin,2 Merrick Brodsky,1 Jessica R Gandy,1 Mio Nakamura,2 Tian Hao Zhu,3 Benjamin Farahnik,4 John Koo,2 and Tina Bhutani, 2 Excimer laser for the treatment of psoriasis: safety, efficacy, and patient acceptability. Published online 2016 Dec 12. doi: 10.2147/PTT.S105047
